rs777420944
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052813.5(CARD9):c.1121G>A(p.Gly374Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000499 in 1,603,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_052813.5 missense
Scores
Clinical Significance
Conservation
Publications
- deep dermatophytosisInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- predisposition to invasive fungal disease due to CARD9 deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CARD9 | NM_052813.5 | c.1121G>A | p.Gly374Asp | missense_variant | Exon 8 of 13 | ENST00000371732.10 | NP_434700.2 | |
| CARD9 | NM_052814.4 | c.1121G>A | p.Gly374Asp | missense_variant | Exon 8 of 13 | NP_434701.1 | ||
| LOC124902309 | XR_007061863.1 | n.246C>T | non_coding_transcript_exon_variant | Exon 2 of 2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CARD9 | ENST00000371732.10 | c.1121G>A | p.Gly374Asp | missense_variant | Exon 8 of 13 | 1 | NM_052813.5 | ENSP00000360797.5 | ||
| ENSG00000289701 | ENST00000696169.1 | n.*168G>A | non_coding_transcript_exon_variant | Exon 8 of 13 | ENSP00000512460.1 | |||||
| ENSG00000289701 | ENST00000696169.1 | n.*168G>A | 3_prime_UTR_variant | Exon 8 of 13 | ENSP00000512460.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000297 AC: 7AN: 235546 AF XY: 0.0000310 show subpopulations
GnomAD4 exome AF: 0.0000524 AC: 76AN: 1451340Hom.: 0 Cov.: 31 AF XY: 0.0000664 AC XY: 48AN XY: 722432 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74364 show subpopulations
ClinVar
Submissions by phenotype
Predisposition to invasive fungal disease due to CARD9 deficiency Uncertain:2
- -
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 374 of the CARD9 protein (p.Gly374Asp). This variant is present in population databases (rs777420944, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with CARD9-related conditions. ClinVar contains an entry for this variant (Variation ID: 580153). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1121G>A (p.G374D) alteration is located in exon 8 (coding exon 7) of the CARD9 gene. This alteration results from a G to A substitution at nucleotide position 1121, causing the glycine (G) at amino acid position 374 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at